MedTrace Logo

Percutaneous Mitral Valve Intervention: Predicting Improvements in Left Ventricular Performance

NCT04156295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2021-07-29

No results posted yet for this study

Summary

The purpose of this study is to assess the role of cardiac imaging combined with demographic, clinical, and biochemical parameters in predicting outcomes following percutaneous mitral valve intervention in order to facilitate more careful risk stratification, interventional planning and avoidance of high risk futile procedures.The principle objective of this study is to determine if transthoracic echocardiography (TTE) can predict changes in left ventricular (LV) size and function following percutaneous mitral valve intervention (PMVI).

Conditions

  • Mitral Regurgitation
  • Mitral Valve Insufficiency

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    collaborator OTHER

  • Manchester Metropolitan University

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Bernard Prendergast, B Med Sc DM · Guy's and St Thomas' NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04156295 on ClinicalTrials.gov